NM_031844.3:c.664G>A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_031844.3(HNRNPU):​c.664G>A​(p.Gly222Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000716 in 1,396,824 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G222V) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.2e-7 ( 0 hom. )

Consequence

HNRNPU
NM_031844.3 missense

Scores

2
1
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.58

Publications

0 publications found
Variant links:
Genes affected
HNRNPU (HGNC:5048): (heterogeneous nuclear ribonucleoprotein U) This gene encodes a member of a family of proteins that bind nucleic acids and function in the formation of ribonucleoprotein complexes in the nucleus with heterogeneous nuclear RNA (hnRNA). The encoded protein has affinity for both RNA and DNA, and binds scaffold-attached region (SAR) DNA. Mutations in this gene have been associated with epileptic encephalopathy, early infantile, 54. A pseudogene of this gene has been identified on chromosome 14. [provided by RefSeq, Jun 2017]
HNRNPU Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 54
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.1258055).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HNRNPUNM_031844.3 linkc.664G>A p.Gly222Ser missense_variant Exon 1 of 14 ENST00000640218.2 NP_114032.2 Q00839-1Q96BA7
HNRNPUNM_004501.3 linkc.634+30G>A intron_variant Intron 1 of 13 NP_004492.2 Q00839-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HNRNPUENST00000640218.2 linkc.664G>A p.Gly222Ser missense_variant Exon 1 of 14 1 NM_031844.3 ENSP00000491215.1 Q00839-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.16e-7
AC:
1
AN:
1396824
Hom.:
0
Cov.:
34
AF XY:
0.00
AC XY:
0
AN XY:
694526
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
28530
American (AMR)
AF:
0.00
AC:
0
AN:
37094
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23910
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34894
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80978
European-Finnish (FIN)
AF:
0.0000272
AC:
1
AN:
36736
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4272
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1092584
Other (OTH)
AF:
0.00
AC:
0
AN:
57826
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 27, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
23
DANN
Uncertain
0.97
DEOGEN2
Benign
0.11
T
Eigen
Benign
-0.59
Eigen_PC
Benign
-0.47
FATHMM_MKL
Benign
0.40
N
LIST_S2
Benign
0.57
T
M_CAP
Pathogenic
0.65
D
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PhyloP100
1.6
PrimateAI
Pathogenic
0.92
D
Polyphen
0.36
B
MutPred
0.31
Gain of glycosylation at G222 (P = 0.0028);
ClinPred
0.28
T
GERP RS
1.2
PromoterAI
-0.0022
Neutral
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
3.5
Varity_R
0.096
gMVP
0.13
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1553283807; hg19: chr1-245026946; API